GE HealthCare (GEHC): financials, SEC filings and peers

GE HealthCare (GEHC) is a health care equipment company in the Health Care sector of the S&P 500, headquartered in Chicago, Illinois.

It was founded in 1994 and joined the S&P 500 on January 4, 2023.

Its fiscal year ends in December, and its shares trade on the Nasdaq.

In its SEC filings it is classified as “X-Ray Apparatus & Tubes & Related Irradiation Apparatus”.

GE HealthCare at a glance

Revenue (12 months): $21.6B
Revenue growth: +6.9%
Operating margin: 13.3%
Net income (12 months): $2.2B
Free cash flow (12 months): $1.9B
Cash: $2.8B
Debt: $10.0B
Diluted EPS (12 months): $4.74

Twelve months to September 30, 2026, from the 10-Q filed October 28, 2026.

Latest twelve months

Over the twelve months to September 30, 2026, GE HealthCare reported revenue of $21.6 billion, about the same as a year earlier (+6.9%).

Its operating margin was 13.3%: for every $100 of sales, about $13 was left as operating profit.

Net income was $2.2 billion (10.0% of revenue), 2.8% lower than a year earlier.

Operating cash flow was $2.4 billion and capital spending $526 million, leaving free cash flow of $1.9 billion (8.7% of revenue).

At the end of the period it held $2.8 billion in cash and $10.0 billion in debt, a net debt position of $7.2 billion.

Five-year trend

Revenue went from $17.6 billion in fiscal 2021 to $20.6 billion in fiscal 2025, about 4.1% a year.
Revenue has grown for 4 fiscal years in a row.
Operating margin narrowed from 15.9% to 13.4% over the same years.
Free cash flow was positive in each of the last 5 fiscal years.

Fiscal year	2021	2022	2023	2024	2025
Revenue	$17.6B	$18.3B	$19.6B	$19.7B	$20.6B
Revenue growth	—	4.3%	6.6%	0.6%	4.8%
Operating margin	15.9%	13.8%	12.5%	13.3%	13.4%
Net income	$2.2B	$1.9B	$1.6B	$2.0B	$2.1B
Free cash flow	$1.4B	$1.8B	$1.7B	$1.6B	$1.5B
Diluted EPS	$4.95	$4.22	$3.03	$4.34	$4.55

Fiscal years as reported in GE HealthCare’s 10-K filings. Free cash flow is operating cash flow minus capital spending.

Recent SEC filings

8-K filed November 5, 2026 — Executive or director change
10-Q filed October 28, 2026 — quarterly report
8-K filed October 28, 2026 — Earnings results; Executive or director change
8-K filed September 22, 2026 — Executive or director change; Regulation FD disclosure
8-K filed August 18, 2026 — Executive or director change
8-K filed July 29, 2026 — Regulation FD disclosure
10-Q filed July 29, 2026 — quarterly report
8-K filed July 29, 2026 — Earnings results

All GE HealthCare filings on SEC EDGAR

Companies like GE HealthCare

Other S&P 500 companies in Health Care Equipment:

More from Health Care

All 60 Health Care companies →

Questions about GE HealthCare

Is GE HealthCare's revenue growing?

Yes. Revenue for the twelve months to September 30, 2026 was $21.6 billion, up 6.9% from a year earlier, according to its SEC filings.

Is GE HealthCare profitable?

Yes. It earned $2.2 billion in net income over the twelve months to September 30, 2026, a net margin of 10.0%.

Does GE HealthCare have more cash or more debt?

At September 30, 2026 it had $2.8 billion in cash and $10.0 billion in debt, so more debt than cash.

When did GE HealthCare last file financial results?

Its latest quarterly report (10-Q) was filed with the SEC on October 28, 2026.

Which companies are similar to GE HealthCare?

In the S&P 500, GE HealthCare is grouped in Health Care Equipment within the Health Care sector. Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Dexcom (DXCM) are in the same group.

Understand the numbers

Source: GE HealthCare’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved November 11, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.